Tuesday, May 14, 2019 6:07:18 AM
Total Monthly Retail ONLY Data April-2019
NON–NORMALIZED Retail ONLY Data April-2019
Amazing Numbers – ATH Across the Board in Numbers & Market Share
V
TRx: 188,920 {vs 177,480; +6.45%} – Sector +1.30% -- ATH
NRx: 79,563 {vs 78,356; +1.54%} – Sector -2.23% -- ATH
Ref: 109,357 {vs 99,124; +10.32%} – Sector +4.05% -- ATH
Gen L
TRx: 203,220 {vs 209,340; -2.92%}
NRx: 86,188 {vs 91,078; -5.37%}
L
TRx: 3,766 {vs 4,000; -5.85%}
NRx: 1,316 {vs 1,448; -9.12%}
Monthly Retail TRx Market Share: 47.72% vs 45.41% --- ATH
Monthly Retail NRx Market Share: 47.62% vs 45.85% --- ATH
Monthly Retail Refills Market Share: 47.79% vs 45.07% --- ATH
April-2019 vs. April-2018 (Retail ONLY Data)
NON–NORMALIZED Retail ONLY Data April-2019 vs 2018
Amazing Year-On-Year Increase Across the Board, ~ 70% increase in TRx & ~ 80% increase in NRx
It is worth mentioning that V is driving the whole sector into positive green territory (Year-On-Year ~+13% TRx ~+18% NRx) and at the same time increasing its own Market Share
V
TRx: 188,920 {vs 111,697; +69.14%} – Sector +12.52% -- ATH
NRx: 79,563 {vs 44,560; +78.55%} – Sector +17.93% -- ATH
Ref: 109,357 {vs 67,137; +62.89%} – Sector +8.87% -- ATH
Gen L
TRx: 203,220 {vs 224,533; -9.49%}
NRx: 86,188 {vs 90,349; -4.61%}
L
TRx: 3,766 {vs 15,629; -75.90%}
NRx: 1,316 {vs 6,762; -80.54%}
V Apr-2019 Retail ONLY TRx Market Share: 47.72% vs 31.74% in Apr-2018 --- ATH
V Apr-2019 Retail ONLY NRx Market Share: 47.62% vs 31.45% in Apr-2018 --- ATH
V Apr-2019 Retail ONLY Ref Market Share: 47.79% vs 31.94% in Apr-2018 --- ATH
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM